Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Xiao‑Yu Teng"'
Autor:
Xiao-Yu Teng, Ping Hu, Cai-Ming Zhang, Qin-Xin Zhang, Guolin Yang, Yan-Yu Zang, Zhi-Xiong Liu, Guiquan Chen, Yun Stone Shi
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 8/6/2024, Vol. 121 Issue 32, p1-11, 11p
Autor:
Ying-Biao Chen, Xiang Li, Meng-Ying Li, Zhen-Zhen Kou, Xiao-Yu Teng, Yang Bai, Yun-Qing Li, Jun-Bin Yin, Ting Zhang, Jia-Ni Li, Jing Chen, Shengxi Wu, Tao Chen, Jing Huang, Xin-Tong Qiu, Jiang-Bo Ma, Ya-Nan Peng, Hui Li
Publikováno v:
Neuroscience. 429:78-91
Enkephalin (ENK) has been implicated in pain modulation within the spinal dorsal horn (SDH). Revealing the mechanisms underlying ENK analgesia entails the anatomical and functional knowledge of spinal ENK-ergic circuits. Herein, we combined morpholog
Autor:
Xiao‐Yu Teng, Ping Hu, Yangyang Chen, Yanyu Zang, Xiaolian Ye, Jingmin Ou, Guiquan Chen, Yun Stone Shi
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyREFERENCES. 36(3)
Leucine-rich glioma-inactivated protein 1 (LGI1) is known to play a key role in autosomal dominant lateral temporal lobe epilepsy (ADLTE). The ADLTE is an inherited disease characterized by focal seizures with distinctive auditory or aphasic symptoms
Autor:
Yan Wang, Fengchang Qiao, Qing-Qing Li, Hao-Yang Feng, Jia-Hui Sun, Ya-Ping Zhou, Qi-Gang Zhou, Tingting Liu, Dan Wu, Xiao-Yu Teng, Zhengfeng Xu, Yan-Yu Zang, Jiang Chen, Ping Hu, Yun Stone Shi
Publikováno v:
CNS Neuroscience & Therapeutics
Aims This study aimed to explore the pathomechanism of a mutation on the leucine‐rich glioma inactivated 1 gene (LGI1) identified in a family having autosomal dominant lateral temporal lobe epilepsy (ADLTE), using a precise knock‐in mouse model.
Autor:
Jian Wang, Ting Zhang, Yong Zhang, Yan Yan Wei, Xiao‑Yu Teng, Zhong‑Fu Zuo, Yun-Qing Li, Yong Hui Liao
Publikováno v:
Molecular Medicine Reports
Chronic pain occurs in ~85–90% of chronic pancreatitis (CP) patients. However, as the pathogenesis of CP pain remains to be fully understood, the current therapies for CP pain remain inadequate. Emerging evidence has suggested that the epigenetic m
Autor:
Wei Qing Chen, Yan Xia Shi, Xiao Yu Teng, Zhong Yu Yuan, Xi Wang, Dong Gen Liu, S. Wang, Tao Qin, Rou Jun Peng
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 13(4)
Purpose: This study aimed to assess possible interactive effects of coping styles and psychological stress on depression and anxiety symptoms in Chinese women shortly after diagnosis of breast cancer. Methods: Four hundred and one patients with breas
Autor:
Dong-Gen, Liu, Shu-Sen, Wang, Rou-Jun, Peng, Tao, Qin, Yan-Xia, Shi, Xiao-Yu, Teng, Xi, Wang, Wei-Qing, Chen, Zhong-Yu, Yuan
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 12(10)
The aim of the present study was to assess the association of psychological stress and social support with anxiety and depressive symptoms in Chinese newly diagnosed breast cancer patients.Four hundred and one patients with breast cancer were recruit
Autor:
Yuting Tan, Dong Geng Liu, Xiao Yu Teng, Yan Xia Shi, Zhong Yu Yuan, Ying Jin, Wen Qi Jiang, S. Wang, Xin An, Ye Cao, Rou Jun Peng, Yue li Sun, Xiu Yu Cai, Qing Xia
Publikováno v:
Journal of cancer research and clinical oncology. 138(4)
The clinical significance of bilateral breast cancer is unclear and its influence on prognosis is controversial. We compared the characteristics and prognosis of bilateral breast cancer and unilateral breast cancer.Our study included 4,183 patients w
Autor:
Zhuo-Wei, Liu, Fang-Jian, Zhou, Hui, Han, Zi-Ke, Qin, Shao-Long, Yu, Yong-Hong, Li, Yun-Lin, Ye, Xiao-Yu, Teng
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 27(12)
Retroperitoneal lymph node dissection(RPLND) is one of the main modalities for nonseminomatous germ cell tumors (NSGCTs). RPLND has achieved relatively high efficacy for stage I/II NSGCTs. Currently, the postoperative complication rate of conventiona
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 27(12)
It has been proved that trastuzumab has clinical activity in early and advanced breast cancer with Her2-overexpression. This study was to analyze the safety of trastuzumab after adjuvant chemotherapy in 30 Chinese Her2-positive early breast cancer pa